Artelo Biosciences Inc
NASDAQ:ARTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Artelo Biosciences Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Artelo Biosciences Does
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. The company is headquartered in Solana Beach, California and currently employs 7 full-time employees. The company went IPO on 2015-10-13. The firm is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, dermatologic conditions, pain, and inflammation.
- Headquarters
- United States of America US
- Employees
- 7
- IPO date
- Oct 13, 2015
